Label: ANATRA- anas barbariae tablet

  • NDC Code(s): 83641-001-01, 83641-001-02
  • Packager: Anatra LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated September 15, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredient

    Anas barbariae. HPUS - 200 CK

  • Purpose

    To reduce the duration and severity of cold & flu-like symptoms. The letters HPUS indicate that this ingredient is officially included in the Homeopathic Pharmacopeia of the United States.

  • Uses

    Temporarily relieves cold & flu-like symptoms such as:

    • Body aches
    • Headache
    • Fever
    • Chills
    • Fatigue
  • Warnings

    Ask a Doctor before usein children under 2 years of age.
    Stop use and ask a Doctor if symptoms persist for more than 3 days or worsen.
    If pregnant or breast-feeding, ask a health professional before use.
    Keep out of reach of children.

  • KEEP OUT OF REACH OF CHILDREN

  • Directions

    ANATRA may be taken regularly as a preventative.
    Adults and children 2 years of age and older: Dissolve entire tablet in mouth every
    6 hours, up to 3 times a day. Children under two years of age: Ask a Doctor.

  • Other Information

    Do not use if carton is open and/or bottle is open.Each 0.775g dose contains 0.5g of sugar. Store at 68-77°F (20-25°C).

  • Inactive ingredients

    Beta Carotene, Citric Acid, Crospovidone, Dextrose,Lactose, Magnesium Stearate, Nat. Orange Flavor, Reb. A (Stevia LeafExtract), Silicon Dioxide, Stearic Acid

  • Questions/Comments?

    Distributed by Anatra LLC 3250 NE 1st Ave., Suite 305 Miami, FL 33137 (844) ANATRA-1

  • Product label

    image descriptionimage descriptionimage descriptionimage description

  • INGREDIENTS AND APPEARANCE
    ANATRA 
    anas barbariae tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:83641-001
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE (UNII: RN2HC612GY) (CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE - UNII:RN2HC612GY) CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE200 [hp_C]
    Inactive Ingredients
    Ingredient NameStrength
    BETA CAROTENE (UNII: 01YAE03M7J)  
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    CROSPOVIDONE, UNSPECIFIED (UNII: 2S7830E561)  
    DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
    LACTOSE, UNSPECIFIED FORM (UNII: J2B2A4N98G)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    REBAUDIOSIDE A (UNII: B3FUD0528F)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    Product Characteristics
    ColororangeScoreno score
    ShapeROUNDSize12mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:83641-001-0130 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product09/01/2023
    2NDC:83641-001-0260 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product09/01/2023
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other09/01/2023
    Labeler - Anatra LLC (121482372)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!